Back to results
US 11,897,863 B2Granted
Indazole amine derivative, preparation method therefor and medical use thereof
AssigneeZhejiang Hisun Pharmaceutical Co., Ltd.
InventorsYongping Lu, Cheng Ye, Wenjian Qian, Taishan Hu, Lei Chen
Life of this patent
Estimating the term…
Abstract
Indazole derivatives represented by formula (I) or stereoisomers, tautomers, and pharmaceutically acceptable salts thereof are provided. A preparation method of indazole derivatives represented by formula (I) and a method of use of the indazole derivatives as therapeutic agents is also provided. The indazole derivatives of formula (I) are especially useful as interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors
Claims18
A compound of formula (I), or stereoisomers, tautomers or pharmaceutically acceptable salts thereof:
- wherein:
- R1 and R2 are independently selected from hydrogen or C 1-C6 alkyl;
- R3 is selected from halogen, cyano, carboxyl, —CONRARB, haloalkyl or heteroaryl;
- wherein the heteroaryl is optionally further substituted by one or more substituents selected from halogen, hydroxyl, cyano, carboxyl, —CONRARB or haloalkyl;
- W is azetidinyl, nitrogen-containing aromatic heterocyclic ring group or nitrogen-containing aromatic heterocyclic ring group bonded via a single methylene group;
- wherein the azetidinyl is optionally further substituted by one or more substituents selected from —CORC, —SO2RD, C1-C6 alkyl or C 3-C6 cycloalkyl;
- wherein the nitrogen-containing aromatic heterocyclic ring group is optionally further substituted by one or more substituents selected from halogen, cyano, carboxyl, —CONRARB and haloalkyl;
- or, W has a structure of formula (II):
- * represents bonding site of the group to rest of the molecule;
- Ra is selected from hydrogen, C 1-C6 alkyl or C 3-C6 cycloalkyl;
- wherein the C 1-C6 alkyl or C 3-C6 cycloalkyl is optionally further substituted by one or more substituents selected from halogen, hydroxyl, carboxyl and —SO2NRERF;
- Rb and Rc are independently selected from hydrogen, —CORC, —SO2RD, C1-C6 alkyl or C3-C6 cycloalkyl;
- or, any two of R a, R b and Rc together with the atoms to which they are attached form a 4-8 membered nitrogen-containing heterocyclic ring, wherein the nitrogen-containing heterocyclic ring may be further substituted by one or more oxo groups (O═);
- RA, R B, R E and R F are independently selected from hydrogen, C1-C6 alkyl or C3-C6 cycloalkyl;
- wherein the alkyl or cycloalkyl is optionally further substituted by one or more substituents selected from halogen, hydroxyl, cyano or haloalkyl;
- RC and R D are independently selected from C1-C6 alkyl or C 3-C6 cycloalkyl;
- wherein the alkyl or cycloalkyl is optionally further substituted by one or more substituents selected from halogen, hydroxyl, cyano or haloalkyl.
14 more elements
Dependencies are inferred from the claim text.